Pfizer’s COVID-19 vaccine: Everything you need to know
Team Udayavani, Nov 10, 2020, 3:04 PM IST
Drugmakers Pfizer and BioNTech have said their experimental vaccine may be 90 percent effective at preventing COVID-19.
While the Pfizer-BioNTech trial has yet to be peer-reviewed by experts, scientists reacted positively, if cautiously to the results.
It is said that Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they have so far found no serious safety concerns.
As reported by abcnews, The vaccine, dubbed BNT162b2, involves two jabs, each three weeks apart. In interim results from the companies’ phase 3 clinical trial, which started in July and has more than 43,000 enrolled participants, they reported 94 lab-confirmed COVID-19 infections.
It is said that vaccine lowers your chances of getting sick by 90 per cent, compared to someone who hasn’t been vaccinated.
Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November
Clinical trial to continue through to final analysis at 164 confirmed cases in order to collect further data and characterize the vaccine candidate’s performance against other study endpoints
As reported by TOI, They now expect to produce up to 50 million doses or enough vaccine to protect 25 million people this year. Pfizer said it expects to produce up to 1.3 billion doses of the vaccine in 2021.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
Father’s diet can affect anxiety in sons, metabolism in daughters: Study in mice finds
Low back pain, depression, headaches main causes of poor health: Study
Surgical options for Parkinson’s disease
MUST WATCH
Latest Additions
Kollegela MLA A.R. Krishnamurthy escapes unhurt in car mishap
Lok Sabha elections 2024: EC takes cognisance of MCC violation by Modi, Rahul; seeks response by April 29
Polali: Case filed against a man for molesting minor
Kotak Mahindra Bank shares tank 13%; mcap erodes by Rs 37,721 crore post RBI action
Lok Sabha polls 2024: Sunita Kejriwal likely to join AAP’s campaign in Delhi, will hold roadshows this weekend